Dr. Cassandra L. Smith
Deputy Director, Center for Advanced
BioTechnology; Director, Molecular BioTechnology Research Laboratory; Professor
of BioMedical Engineering, Biology & Pharmacology, Boston University
College of Engineering; Boston MA, USA; Editor-in-Chief, BioMolecular
Engineering (Elsevier) and Editorial Board Member, International Journal of
BioSciences and Technology
Dr. Smith is the Deputy Director of the Center for Advanced Biotechnology, Director of the Molecular Biotechnology Research Laboratory and Professor of Biomedical Engineering (College of Engineering), Professor of Biology (College of Arts and Sciences), and Professor of Pharmacology and Experimental Therapeutics (College of Medicine) at Boston University. Prior to 1992, Dr. Smith was an Associate Professor at the University of California, Berkeley and Senior Scientist at the Lawrence Berkeley Laboratory; and before then, an Assistant Professor in the Departments of Psychiatry and Microbiology at Columbia University Medical School in New York City.
Dr. Smith consults extensively in industry: in the past, Roche, Boehringer-Mannheim, Pharmacia-LKB, FMC Corporation, Promega, Sequenom, Avitech; and more recently, for Biokit, New York State Office of Technology and Science, Philip Morris External Research Program, Moors and Cabot, Bosch, Mu-Vision among others and recently founded a start-up biotechnology, Daxx. She has served as an expert advisor and witness to the San Francisco Public Defender's Office and State of Massachusettes Superior Court, on a number of review panels for the Department of Energy, the National Academy of Sciences, the Department of the Army, the National Institutes of Health and the National Science Foundation. Dr. Smith has extensive editorial experience and is now and serves on the editorial board of Twin Research and Human Genetics, Recent Patents in Biotechnology.
Dr. Smith's has authored over 200 scientific publications, and holds 14 patents with research that has spanned microbiology, biochemistry, genetics, biotechnology, genomics and psychiatry. She is known for technical innovation and for tackling and solving difficult research projects. She was instrumental in developing pulsed field gel electrophoresis and the accompanying large DNA technology that opened up genomic studies to virtually all organisms, and developed a number of approaches for comparative genomic studies including DNA arrays and other differential display methodology as well as new DNA amplification methods. A recent major focus is on preventing/minimizing schizophrenia. Other research is developing new targeting reagents made of nucleic acid for early diagnosis and treatment of tumors.
click here to view a detailed
biography of Dr.Cassandra L. Smith
International Journal of BioSciences and Technology (IJBST) ISSN: 0974-3987 > Journal Editorial Board >